Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Trillium Therapeutics Inc. (TRIL) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $10.08 Metrics
OS: 105.0 M
Market cap: $1.06 B
Net cash: $251 M $2.39 per share
EV: $808 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-17Dec-31-16Dec-31-15
Revenues0.10.137.129.818.1
            Revenue growth19.4% 24.7%65.0% 
Cost of goods sold0.00.00.00.00.0
Gross profit0.10.137.129.818.1
            Gross margin100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative  41.033.7 
Research and development25.326.7   
General and administrative36.35.73.93.93.2
EBITA-61.5-32.30.0-0.2-2.8
            EBITA margin-41523.6%-26038.7%0.0%-0.8%-15.8%
Amortization of intangibles  3.93.70.3
EBIT-61.5-32.3-3.9-3.9-3.2
            EBIT margin-41523.6%-26038.7%-10.4%-13.2%-17.6%
Pre-tax income-59.2-38.145.135.414.7
Income taxes0.10.00.0-3.70.0
            Tax rate  0.0% 0.0%
Net income-59.3-38.10.00.00.0
            Net margin-40098.6%-30711.3%0.0%0.0%0.0%
 
Diluted EPS($0.70)($1.51)   
Shares outstanding (diluted)84.625.3   
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy